INTRODUCTION
Pseudobulbar affect (PBA) is a neurologic syndrome of emotional affect disinhibition, characterized by frequent, uncontrollable emotional outbursts of crying and/or laughing that are usually exaggerated and inappropriate to the stimulus, and may be mood incongruent. [1] [2] [3] Some patients may also display outbursts of anger or frustration. 4 PBA occurs primarily in patients with neurologic conditions, stroke, or traumatic brain injury (TBI) and has been reported in patients with brain injury from numerous other causes, such as tumors, aneurysms, and herpes encephalitis. 3, 5 Although its etiology is unclear,
PBA is thought to be caused by the presence of brain lesions interfering with neural circuits and neurotransmitters that regulate voluntary and perhaps over-learned involuntary emotional expression. 2, 3 Clinical syndromes of abnormal emotional expression in patients with brain lesions or injury have been noted since at least the late 19th century and defined with varying terms and descriptions, including pathological laughter and crying (PLC), involuntary emotional expression disorder, and emotional lability. 1, 6 Clinical case and study data have shown that PBA may cause severe distress, embarrassment, and social disability among patients. 3, [7] [8] [9] [10] In addition, studies have shown that patients with PBA or similar syndromes experience an increased incidence of depression, 11 impairments in executive function 12 and sexual function, 13 and ability to perform activities of daily living 14 10, 11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] ). This variability is probably due to differences in the populations studied and in the criteria and methods used for identifying PBA. 1, 3 Yet, no previous study has sought to estimate the prevalence of PBA across different disorders using similar criteria and methods of identification.
In addition, several researchers have observed that PBA is generally under-recognized, Figure 1 . Ranges of estimated prevalence for PBA and similar syndromes, such as emotional lability as variously defined and identified in published reports are indicated by the vertical gray arrows. 5, 10, 11, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Prevalence rates determined in the present study with PLACS≥13 and CNS-LS≥13 are indicated by the transverse plot points. The prevalence rates determined with CNS-LS≥21 in the present study were very similar to those for PLACS≥13, and are not shown here to enhance visual clarity. AD=Alzheimer's disease; ALS=amyotrophic lateral sclerosis; MS=multiple sclerosis; PD=Parkinson's disease; TBI=traumatic brain injury.
misdiagnosed, and under-treated, although there are few data to quantify these observations. 1, 3, 8, 33 We conducted an online survey among patients in the USA with six underlying conditions commonly associated with PBA -ALS, MS, stroke, AD/dementia, TBI, and PD -in order to prospectively estimate the overall prevalence of PBA and quantify the extent to which PBA is diagnosed and treated. Secondary goals were to investigate patterns of physician recognition, diagnosis, and treatment of PBA.
MATERIALS AND METHODS

Survey Overview
This stratified sample survey was designed and directed by the authors. Avanir Pharmaceuticals commissioned the study, which was conducted by Harris Interactive ® (HI), a market research firm specializing in public opinion and consumer surveys (http://www.harrisinteractive.com).
Both patients with PBA and caregivers were surveyed to ensure participation of more severely incapacitated patients.
Study Sample
The study sample was drawn from a nationally representative sample of more than 6 million US (Table 1) .
Study Measures
To identify PBA, participants were asked to complete the Pathological Laughing and Crying Scale (PLACS), 31 and the Center for Neurologic Study-Lability Scale (CNS-LS), 4, 35 which includes an auxiliary subscale for episodes of anger/ frustration. Patients and caregivers were asked the same questions, with caregivers answering based on their observations of the patient.
PLACS
The PLACS is an interviewer-rated instrument that measures the severity of PBA symptoms, and has been validated in stroke patients. 31 Eight items of the scale relate to laughing and eight to crying. The scale begins with two screening questions asking if the respondent *As TBI is not included as part of the Harris Chronic Illness Panel, the potential sample pool was unknown and thus quota limits for TBI were difficult to anticipate; therefore, quota limits for TBI were set at 250 to 500. †As TBI is not included as part of the Harris Chronic Illness Panel, TBI was identified by sending survey invitations to panel members with chronic headaches, posttraumatic stress disorder (PTSD), or general disability, and inquiring whether these members had been diagnosed by a physician or other healthcare professional with TBI, defined as a head injury requiring hospitalization, which resulted from being knocked unconscious, having a skull fracture, or suffering other brain injury. Therefore, a greater number of invitations were sent to these groups in order to identify a sufficient number of patients with TBI. ‡Source 1: Prevalence was derived from the following professional and government organization Web sites: 1. ALS: The ALS Association. 6 . TBI: Centers for Disease Control (CDC) and National Center for Injury Prevention and Control (NCIPC) estimate of Americans who currently have a long-term or lifelong need for help to perform activities of daily living as a result of a TBI. 43 §Source 2: Prevalence was calculated from approximate point prevalence rates per 100,000 population (all ages) provided by Wallin and Kurtzke, 2004 44 multiplied by 2988, ie, the approximate total current USA population divided by 100,000. The number used for the total USA resident population (298,755,510) was derived from the Population Division of the United States Census Bureau. 45 ||Motor neuron disease. ¶Rate for high-risk areas. #Acute cerebrovascular disease and subarachnoid hemorrhage. AD=Alzheimer's disease; CNS-LS=Center for Neurologic Study-Lability Scale; MS=multiple sclerosis; PBA=pseudobulbar affect; PD=Parkinson's disease; PLACS=Pathological Laughing and Crying Scale; TBI= traumatic brain injury.
has experienced laughing or crying episodes; if either question or both are answered "rarely or no," the following questions related to laughing or crying, or the rest of the scale, is not administered. Each item/symptom is scored for severity on a scale of 0 to 3 points (0=rarely or not at all, 3=frequently), and then totaled to obtain an overall score. In stroke patients, a PLACS cut-off total score of ≥13 (PLACS≥13) has been shown to distinguish individuals with PBA, with a sensitivity for clinically diagnosed PBA of 0.88, a specificity of 0.96, and a positive predictive value of 0.83 (n=67). 31 The PLACS has not been validated in other populations. For purposes of this survey, the PLACS questions were revised to allow for self-administration.
CNS-LS and Auxiliary Subscale
The CNS-LS is a self-report measure of PBA that has been validated in both ALS 4 and MS 
Prevalence Estimates
Prevalence estimates for each of the six underlying neurological conditions were derived from two sources: professional and government organizations that serve as resources for US disease-prevalence data ( ). 44, 46, 47 These data were found to be divergent, indicating lack of consensus on these statistics, with estimates generated by professional and government organizations being generally higher than those from published research reports cited in the textbook. Therefore, it was deemed prudent and appropriate to present both sets of data. 
Statistical Analysis
Weighting for Demographic Variables and Proportionality
To adjust for potential bias due to nonresponse and to ensure that the sample was representative of the US adult population in each disease group, patient data for four of the six underlying conditions were weighted. 48 
Margin of Sampling Error
With probability samples the size of this survey sample (n=2318), there is 95% certainty that the results have a sampling error of ±2%.
Although the online sample does not meet the strict criteria of a probability sample, a similar margin of sampling error is expected here.
Analysis of individual neurological conditions yields a larger sampling error due to smaller sample sizes ( Table 1 ). The margin of error at the 95% confidence interval (CI) is approximately 4% to 6% for the various conditions, with the exception of the smaller ALS sample (n=40), for which the margin of error is about 16%.
Backfill of Missing Data
The 
RESULTS
Survey Population
A in both the MS and stroke groups (Table 1) .
PBA Prevalence
The CNS-LS scale with a cut-off score of ≥13 yielded larger estimates of PBA prevalence within and across the disease groups, compared with the higher CNS-LS threshold of 21 points (CNS-LS≥21) and the PLACS cutoff of ≥13, which produced similar rates ( Table 1 ). The mean prevalence estimate of PBA across all six diseases was 10.1% as identified by a PLACS≥13 score;
9.4% with the CNS-LS≥21 score; and 37.5% with a CNS-LS≥13 cutoff. PBA prevalence estimates differed substantially among the six neurologic conditions evaluated, being highest in ALS and lowest in PD, regardless of the criteria used (Table 1) .
US Population Estimates
Application of the PLACS≥13 and CNS-LS≥21
estimates for PBA to prevalence estimates from the US government and from professional organizations for the six underlying conditions yielded similar prevalence estimates for PBA, while the CNS-LS≥13 threshold derived markedly higher estimates ( 
Diagnosis of PBA
Of the 937 respondents who screened positive for PBA using CNS-LS≥13 and/or reported sudden episodes of crying and/or laughter, 637 (73.6% weighted) said they had discussed their episodes of laughing and/or crying with a physician. Of the respondents who discussed their sudden crying/laughter with a physician, 41% were given a diagnosis for the episodes (Table 2) , which, as reported by the patients/ caregivers, was most often depression, or that the symptoms were related to their underlying illness; however, no respondents reported a diagnosis of PBA, PLC, or related terminology ( Figure 2 ). of patients were receiving treatment for PBA. 52 The present estimates of 27.5%, 32.5%, and 50% PBA prevalence in ALS patients identified with the CNS-LS≥21, PLACS≥13, and CNS-LS≥13 thresholds, respectively, are thus within the range of previously reported and clinically accepted estimates.
In patients with AD, the reported prevalence of nonspecific emotional lability has ranged from about 25% to 74%. 3, 53, 54 A study that identified PLC using a semi-structured interview based on Poeck's criteria for diagnosis of PBA, which require that the episodes are provoked by nonspecific stimuli, are uncontrollable, and do not reflect the subjective affective state or influence the prevailing mood, 55, 56 found that 40 (39%) of 103 patients with AD screened positive for PBA. 22 Patients in this study were also given a comprehensive battery of psychological and cognitive tests (including the PLACS)
to identify correlates of pathological affect.
Respective PLACS scores were 0.0 and 1.8 in patients without pathological affect compared with 0.0 and 11.9 in patients diagnosed with pathological crying and 1.8 and 7.3 in patients diagnosed with mixed pathological affect. The prevalence of PBA in this trial is consistent with the estimate of 38.5% found in the present study using the CNS-LS≥13 threshold, and is about four times higher than both the 9.2% and 9.6% prevalence estimates using PLACS≥13
and CNS-LS≥21, respectively. In MS patients, estimates of PBA prevalence have ranged from 7% to 29%. Reported PBA prevalence rates in PD patients are typically lower than those in patients with ALS, dementia, and MS and have ranged from 5.1% to 16.8%. 5, 11, 14, 58 This survey also showed a lower prevalence of PBA in PD patients of 5% using the PLACS≥13 cutoff, while the CNS-LS≥21
yielded a lower estimate of 3.6%, and the CNS-LS≥13 threshold derived a markedly higher estimate of 24% (Table 1 ). In studies that used criteria similar to this survey for the detection of PBA in PD patients, one (n=193) reported a PBA prevalence of 7%, based on the Cummings criteria, which require that PBA episodes cause clinically significant distress or impairment in social or occupational functioning. 58, 59 This study also found that CNS-LS cut-off scores of ≥13 and ≥17 yielded rates of 42.5% and 16.6%, respectively, of patients with "clinically significant PBA symptoms." Notably, a CNS-LS cutoff of ≥11 provided the maximum sensitivity (93%) and specificity (51%) when correlated with the Cummings criteria results.
The inability to obtain both high sensitivity and specificity with the CNS-LS in this study would raise questions as to the validity of this scale in PD patients. 58 However, another study in patients with movement disorders (n=269), which used a CNS-LS≥17 cutoff, reported a 7.1%
prevalence of PBA in a subgroup of patients with PD (n=168), almost the same rate as found with the Cummings criteria. 5 Therefore, both the 5% and 3.6% estimates based on PLACS≥13
cutoff, and CNS-LS≥21, respectively, in this survey appear to be conservative and consistent with prevalence estimates obtained using structured interviews.
Studies in stroke patients have reported prevalence of crying and laughing syndromes ranging from about 6% to 52%. 9, 12, [27] [28] [29] [30] 60 None of these studies used the CNS-LS or the PLACS to identify PBA, although the PLACS has been validated in stroke patients, and a score of 13 was found to identify patients with PBA (sensitivity=0.88, specificity=0.96, positive predictive value=0.83). 31 Several used the "Kim criteria" for emotional incontinence, which require that the patient has shown excessive and/or inappropriate laughter or crying or both, as compared with the premorbid state, on at least two occasions. 12, 27, 29, 60 Three studies used the "House criteria" for emotionalism, described as tearfulness that is more frequent than before the stroke, sudden and uncontrollable, but without regard to appropriateness of the expression. 9, 29, 30 In this survey, the PBA prevalence in stroke of 4.7% and Only two previous studies have reported PBA prevalence in TBI. 10, 32 In one study, 16 (5.3%) of 301 hospitalized patients with TBI were identified as having PBA based simply on whether the patients were observed by clinicians to laugh or cry excessively in response to minimal stimulation. 32 The other study, which used criteria similar to that of Poeck to identify PBA, and the PLACS as a measure of PBA symptom severity, found that 10 of 92 (10.9%) hospitalized patients with TBI had PBA, and the mean (SD) PLACS score for these patients was 13.6 (4.6). 10 In comparison, the present survey found considerably higher PBA rates in TBI patients of 17.4% and 15.5% using PLACS≥13
and CNS-LS≥21 thresholds, respectively, and 48.2% with the CNS-LS≥13 cutoff.
Overall, PBA prevalence in this survey, as estimated using PLACS≥13 and CNS-LS≥21 The considerable prevalence of PBA identified by these survey results highlight the need for improved recognition, diagnosis, and treatment.
However, less than half (41%) of survey participants who discussed their inappropriate laughing and crying episodes with a physician were given a diagnosis, and in no case was the reported diagnosis PBA (Figure 2 
